Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of doxofylline on sevoflurane recovery
ChiCTR2400080165Phase 4Not yet recruiting
- Sponsor
- Taizhou Hospital of Zhejiang Province
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of doxofylline in Anesthesia-related recovery impairment (ARRI) (2 arms), sponsored by Taizhou Hospital of Zhejiang Province. Primary endpoints: Anesthesia recovery time and Postoperative pain score. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
doxofylline
03
Conditions
Anesthesia-related recovery impairment (ARRI)
Beyond the preview
Go deeper on ChiCTR2400080165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080165.